Frontiers in Pharmacology | Renal Pharmacology

Original Research

Published on 21 May 2024

Nimbidiol protects from renal injury by alleviating redox imbalance in diabetic mice

in Renal Pharmacology

Subir Kumar Juin
Sathnur Pushpakumar
Utpal Sen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1369408

1,957 views
1 citation

Review

Published on 21 May 2024

Effects of cell-free DNA on kidney disease and intervention strategies

in Renal Pharmacology

Mingying Zhang
Yubin Cai
Xiaoze Zhong
Weijun Liu
Yuan Lin
Zhanyi Qiu
Ruihuang Liang
Huibo Wei
Kefei Wu
Qinghua Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1377874

2,158 views

Review

Published on 20 May 2024

Application of biological agents in the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis

in Renal Pharmacology

Weijun Liu
Guanyuan Tian
Chao Chen
Mingying Zhang
Zhanmao Chen
Tietao Chen
Zhibin Lin
Wuzhong Wu
Yiqaing Wu
Kefei Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1378384

3,353 views
1 citation

Review

Published on 07 May 2024

Mechanism of tacrolimus in the treatment of lupus nephritis

in Renal Pharmacology

Ming Wang
Jing Zhou
Qiyan Niu
Hongyue Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1331800

5,664 views
6 citations

Original Research

Published on 01 May 2024

Pre-operative maintenance of angiotensin-converting enzyme inhibitors is not associated with acute kidney injury in cardiac surgery patients with cardio-pulmonary bypass: a propensity-matched multicentric analysis

in Renal Pharmacology

Pierre Guilleminot
Stefan Andrei
Maxime Nguyen
Osama Abou-Arab
Emmanuel Besnier
Belaid Bouhemad
Pierre-Grégoire Guinot
Collaborator study group
Jean-Baptiste Anciaux
Annouck Appriou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1343647

2,525 views

Original Research

Published on 26 Apr 2024

A Chinese patent medicine’s long-term efficacy on non-dialysis patients with CKD stages 3–5: a retrospective cohort study

in Renal Pharmacology

Hui-Fen Chen
Yu-Jie Lin
Yan Han
Xian-Long Zhang
Ruo-Bing Wang
Jun-Hui Chen
Ying Pi
Li-Zhe Fu
Fang Tang
Xi-Na Jie

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1379338

1,919 views
1 citation

Review

Published on 22 Apr 2024

The molecular mechanisms of peptidyl-prolyl cis/trans isomerase Pin1 and its relevance to kidney disease

in Renal Pharmacology

Shukun Wu
Yurong Zou
Xiaoqiu Tan
Shuang Yang
Tangting Chen
Jiong Zhang
Xingli Xu
Fang Wang
Wei Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1373446

2,851 views

Original Research

Published on 27 Mar 2024

Influence of the combination of SGLT2 inhibitors and GLP-1 receptor agonists on eGFR decline in type 2 diabetes: post-hoc analysis of RECAP study

in Renal Pharmacology

Yoshimi Muta
Kazuo Kobayashi
Masao Toyoda
Atsuhito Tone
Daisuke Suzuki
Daisuke Tsuriya
Hideo Machimura
Hidetoshi Shimura
Hiroshi Takeda
Hisashi Yokomizo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1358573

5,168 views
6 citations

Original Research

Published on 27 Mar 2024

Aristolochic acid induces acute kidney injury through ferroptosis

in Renal Pharmacology

Xuan Huang
Ruihua Liu
Cuixia Zhan
Haishan Wu
Jinjin Fan
Zhijian Li
Xiao Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1330376

2,503 views
2 citations

Systematic Review

Published on 26 Mar 2024

Effect of uric acid reduction on chronic kidney disease. Systematic review and meta-analysis

in Renal Pharmacology

Alfredo G. Casanova
Ana I. Morales
Laura Vicente-Vicente
Francisco J. López-Hernández

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1373258

3,780 views
8 citations

Systematic Review

Published on 21 Mar 2024

Efficacy of traditional Chinese medicine versus angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and their combinations in the treatment of IgA nephropathy: a systematic review and network meta-analysis

in Renal Pharmacology

Sijia Ma
Yuhua Jiang
Linlin Qian
Meng Wang
Shijie Xu
Guowei Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1374377

2,554 views
1 citation

Original Research

Published on 20 Mar 2024

Astragaloside IV attenuates renal tubule injury in DKD rats via suppression of CD36-mediated NLRP3 inflammasome activation

in Renal Pharmacology

Xianhong Li
Xin Dong
Liangyou Zhang
Shu Zhang
Weiying Huang
Chao Wang
Zhihao Huo
Xin Li
Xiwen Zhang
Xiaotong Jia

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1285797

3,653 views
8 citations

Review

Published on 13 Mar 2024

Extracellular vesicles in chronic kidney disease: diagnostic and therapeutic roles

in Renal Pharmacology

Yixuan Zheng
Hui Wang
Xueying Li
Jing Xie
Junming Fan
Sichong Ren

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1371874

3,818 views
4 citations

Review

Published on 08 Mar 2024

Arachidonic acid metabolism as a therapeutic target in AKI-to-CKD transition

in Renal Pharmacology

Xiao-Jun Li
Ping Suo
Yan-Ni Wang
Liang Zou
Xiao-Li Nie
Ying-Yong Zhao
Hua Miao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1365802

5,102 views
9 citations

Correction

Published on 06 Mar 2024

Corrigendum: Persistent activation of autophagy after cisplatin nephrotoxicity promotes renal fibrosis and chronic kidney disease

in Renal Pharmacology

Ying Fu
Yu Xiang
Wenwen Wu
Juan Cai
Chengyuan Tang
Zheng Dong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1387592

1,237 views
1 citation

Systematic Review

Published on 27 Feb 2024

Efficacy and safety of nonsteroidal mineralocorticoid receptor antagonists for renal and cardiovascular outcomes in patients with chronic kidney disease: a meta-analysis of randomized clinical trials

in Renal Pharmacology

Qianlan Chen
Guocui Wei
Yanping Wang
Xiuxia Li
Qian Zhao
Ling Zhu
Qing Xiao
Xuan Xiong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1338044

3,031 views
4 citations